Ki67 has been proposed as a prognostic biomarker for Ewing sarcoma, although here we specifically identified a sub-group of cells that were Ki67 positive but relatively CD99 negative, that is the nuclear/cytoplasmic ratio of the CD99 marker was less than 1 (Figure S9 in File S1). This evidence concerns the gene CD99 and Ewing sarcoma.